Atossa Therapeutics Ownership | Who Owns Atossa Therapeutics?


OverviewForecastFinancialsChartTranscripts

Atossa Therapeutics Ownership Summary


Atossa Therapeutics is owned by 5.25% institutional investors, 0.33% insiders, and 94.42% retail investors. Blackrock is the largest institutional shareholder, holding 7.34% of ATOS shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.05% of its assets in Atossa Therapeutics shares.

ATOS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAtossa Therapeutics5.25%0.33%94.42%
SectorHealthcare Stocks 232.12%10.72%-142.83%
IndustryBiotech Stocks 383.51%10.54%-294.04%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock9.20M7.34%$10.94M
Vanguard group6.15M4.76%$3.63M
Ameriprise financial2.95M2.29%$2.56B
Renaissance2.06M1.60%$1.22M
Blackrock funding, inc. /de2.00M1.55%$1.18M
Geode capital management1.37M1.06%$809.62K
State street454.50K0.35%$394.05K
Ubs group390.01K0.30%$230.10K
Connor, clark & lunn investment management266.01K0.21%$156.95K
Northern trust263.38K0.20%$228.35K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
R squared28.10K0.01%$16.58K
Point72 asia (singapore) pte.44.11K0.01%$38.24K
Greenberg financial group18.22K0.00%$10.75M
Graham capital management165.45K0.00%$143.44K
Renaissance2.06M0.00%$1.22M
Lvm capital management ltd/mi21.00K0.00%$12.00K
Xtx topco24.85K0.00%$21.54K
Planning capital management1.00K0.00%$1.19K
Ameriprise financial2.95M0.00%$2.56B
Pfg investments21.75K0.00%$12.83K

Top Buyers

HolderShares% AssetsChange
Blackrock9.20M0.00%6.45M
Renaissance2.06M0.00%514.17K
Graham capital management165.45K0.00%165.45K
Susquehanna group, llp226.18K-154.40K
Ubs group390.01K-129.29K

Top Sellers

HolderShares% AssetsChange
Laurion capital management lp---2.23M
Y-intercept (hong kong)---386.33K
Goldman sachs group---334.95K
Gsa capital partners llp---310.75K
Qube research138.64K0.00%-277.73K

New Positions

HolderShares% AssetsChangeValue
Graham capital management165.45K0.00%165.45K$143.44K
R squared28.10K0.01%28.10K$16.58K
Stonex group19.87K0.00%19.87K$11.72K
Greenberg financial group18.22K0.00%18.22K$10.75M
Rockefeller capital management5.00K-5.00K$4.33K

Sold Out

HolderChange
Eversource wealth advisors-2.00
Larson financial group-20.00
Capital performance advisors llp-25.00
True wealth design-29.00
Twin peaks wealth advisors-100.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202518-74.29%6,781,735-65.01%52.33%7-65.00%2-92.00%
Sep 30, 202520-76.74%6,698,329-68.63%51.90%6-85.00%3-88.00%
Jun 30, 202586-21,349,077-24.72%163.43%3944.44%25-19.35%
Mar 31, 202586-1.15%28,358,791-5.26%213.88%27-32.50%3147.62%
Dec 31, 202487-4.40%29,932,7169.47%235.04%4011.11%21-19.23%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF3.94M3.05%-
Vanguard Total Stock Mkt Idx Inv3.85M2.98%-85.03K
iShares Russell 2000 ETF3.15M2.44%-
Columbia Small Cap Value Discv A2.09M1.62%57.50K
Columbia Small Cap Value I A2.09M1.62%57.50K
Columbia Small Cap Value I2.04M1.58%2.04M
Columbia Small Cap Value Discovery Fund2.04M1.58%2.04M
Fidelity Small Cap Index1.29M1.00%-
Vanguard Institutional Extnd Mkt Idx Tr1.17M0.90%-501.45K
iShares Russell 2000 Value ETF1.01M0.78%-

Recent Insider Transactions


DateNameRoleActivityValue
May 21, 2025QUAY STEVEN C President & CEOBuy$9.89K
Mar 26, 2025Remmel H. Lawrence-Buy$7.00K
Apr 10, 2024Finn Jonathan-Buy$44.25K
Nov 15, 2023WEAVER GREGORY L Former EVP, CFO, & DirectorSell$32.50K
Jun 20, 2023WEAVER GREGORY L EVP & CFOBuy$48.50K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q21-
2025 Q11-
2024 Q21-

ATOS Ownership FAQ


Who Owns Atossa Therapeutics?

Atossa Therapeutics shareholders are primarily institutional investors at 5.25%, followed by 0.33% insiders and 94.42% retail investors. The average institutional ownership in Atossa Therapeutics's industry, Biotech Stocks , is 383.51%, which Atossa Therapeutics falls below.

Who owns the most shares of Atossa Therapeutics?

Atossa Therapeutics’s largest shareholders are Blackrock (9.2M shares, 7.34%), Vanguard group (6.15M shares, 4.76%), and Ameriprise financial (2.95M shares, 2.29%). Together, they hold 14.38% of Atossa Therapeutics’s total shares outstanding.

Does Blackrock own Atossa Therapeutics?

Yes, BlackRock owns 7.34% of Atossa Therapeutics, totaling 9.2M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 10.94M$. In the last quarter, BlackRock increased its holdings by 6.45M shares, a 234.28% change.

Who is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested?

R squared is Atossa Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.01% of its assets in 28.1K Atossa Therapeutics shares, valued at 16.58K$.

Who is the top mutual fund holder of Atossa Therapeutics shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Atossa Therapeutics shares, with 3.05% of its total shares outstanding invested in 3.94M Atossa Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools